• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Waters Enhances Alliance iS HPLC System Software, Setting a New Standard for End-to-End Traceability and Data Integrity

    6/17/25 10:00:00 AM ET
    $WAT
    Biotechnology: Laboratory Analytical Instruments
    Industrials
    Get the next $WAT alert in real time by email

    News Summary

    • Industry-first smart HPLC system to provide authenticated user access verification on onboard touchscreen for superior security.
    • Integration of Alliance™ iS HPLC System with Empower™ Software ensures user actions are identifiable and auditable.
    • Minimizes common user errors by up to 40% and enhances audit readiness by providing end-to-end traceability and data integrity.

    BRUGES, Belgium and MILFORD, Mass., June 17, 2025 /PRNewswire/ -- 54th International Symposium on High-Performance Liquid Phase Separations and Related Techniques - Waters Corporation (NYSE:WAT) today announced the release of the Alliance iS HPLC System Software version 2.0, a significant advancement that delivers comprehensive, end-to-end traceability and enhanced data security for the pharmaceutical industry. Bringing the same secure architecture synonymous with Empower Software to the Alliance iS HPLC System touchscreen will enhance compliant monitoring and intuitive traceability for customers. Globally, more than 80% of novel drugs have been submitted to regulatory authorities using Empower Software.1

    The Alliance iS HPLC System delivers leading touchscreen security by offering individual and identifiable access control with user authentication.

    With this release, the Alliance iS HPLC System delivers leading touchscreen security by offering individual and identifiable access control with user authentication. This innovation further reinforces the system's position as the most intelligent HPLC available today, setting a new benchmark for traceability while enhancing troubleshooting and operational efficiency. It ensures uncompromised data integrity from sample to result.

    "Traceability plays an important role in the security and integrity of pharmaceutical data, and the FDA considers the absence of records to be highly significant when data discrepancies are observed," said James Hallam, Vice President, Liquid Chromatography-Mass Spectrometry, Waters Corporation. "Regulators expect to see full audit trails for human interaction with data and systems, and the integration of Empower Software user access control with the Alliance iS HPLC System sets a new standard for end-to-end traceability and data integrity in the QC laboratory."

    The integration further enhances the simplicity of the Alliance iS HPLC System, which reduces human errors by up to 40% and enhances productivity in the QA/QC lab through innovative system intelligence that addresses errors before they can occur.2

    In addition to its intuitive and secure design, the Alliance iS HPLC Platform has earned the Accountability, Consistency, and Transparency (ACT) Ecolabels from My Green Lab, a nonprofit organization dedicated to building a global culture of sustainability in science. The product line was recognized for its sustainable manufacturing practices and error-reducing capabilities, underscoring the Company's commitment to reducing environmental impacts.

    Alliance iS HPLC System Software version 2.0 will be available from August 2025.

    Additional Resources:

    • Audit trail white paper
    • Alliance iS HPLC Landing Page
    • FDA Title 21 Chapter 1 Subchapter A part 11: FDA Title 21 Chapter 1 Subchapter A Part 11: Electronic Records, Electronic Signatures

    Alliance and Empower are trademarks of Waters Technologies Corporation.

    ABOUT: Waters Corporation (NYSE:WAT) is a global leader in analytical instruments, separations technologies, and software, serving the life, materials, food, and environmental sciences for over 65 years. Our Company helps ensure the efficacy of medicines, the safety of food and the purity of water, and the quality and sustainability of products used every day. In over 100 countries, our 7,600+ passionate employees collaborate with customers in laboratories, manufacturing sites, and hospitals to accelerate the benefits of pioneering science.

    Contact:

    Molly Gluck

    Head of External Communications

    Waters Corporation

    [email protected]

    Mobile: +1.617.833.8166

    References

    1. Presented at the J.P. Morgan 43rd Annual Healthcare Conference. According to internal analysis, ~80% of the drugs filed with the FDA, EMA, and China National Medical Products Administration (NMPA) in 2023 were done so using Empower Software. Source: Waters data and estimates.
    2. Estimate based on Waters market research in 2022 after surveying 56 global pharmaceutical company QC labs.

    Waters Corporation (PRNewsfoto/Waters Corporation)

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/waters-enhances-alliance-is-hplc-system-software-setting-a-new-standard-for-end-to-end-traceability-and-data-integrity-302483925.html

    SOURCE Waters Corporation

    Get the next $WAT alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $WAT

    DatePrice TargetRatingAnalyst
    3/31/2025$460.00Sector Weight → Overweight
    KeyBanc Capital Markets
    3/26/2025$396.00 → $407.00Neutral → Outperform
    Robert W. Baird
    2/13/2025$450.00Sector Perform → Sector Outperform
    Scotiabank
    2/10/2025$360.00 → $415.00Underweight → Equal Weight
    Barclays
    1/10/2025$430.00Mkt Perform → Outperform
    Bernstein
    12/23/2024Sector Perform
    Scotiabank
    10/8/2024$355.00 → $415.00Hold → Buy
    Jefferies
    8/28/2024$380.00Overweight
    Wells Fargo
    More analyst ratings